HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales
New Weapons Emerge in the Fight Against Deadly Superbugs
This review summarizes available and emerging therapies for carbapenem-resistant Enterobacterales. It highlights the lack of robust clinical…
New drug combinations offer hope for patients facing deadly superbugs that resist almost all current antibiotics.
Frontiers
Apr 18, 2026
Infectious Disease
Surveillance reports show increasing NDM-CRE cases in New York City from 2019 to 2024
Health officials report rising cases of drug-resistant bacteria in New York City
A surveillance report from New York City documented an increase in New Delhi metallo-β-lactamase-positive carbapenem-resistant Enterobactera…
New York City health officials report rising cases of a drug-resistant bacteria tracked from 2019 to 2024.
CDC
Apr 4, 2026
Infectious Disease
Meta-analysis
FMT and SDD show efficacy for CRE decolonisation in meta-analysis of 872 participants
Can gut bacteria transplants help clear dangerous drug-resistant infections?
A systematic review and meta-analysis of 16 studies with 872 participants found faecal microbiota transplantation (FMT) significantly improv…
Gut bacteria transplants significantly clear dangerous drug-resistant infections, while a targeted antibiotic rinse helps some but may incre…
Apr 3, 2026